Mesoblast Limited (ASX:MSB)
Australia · Delayed Price · Currency is AUD 2.230
0.00 (0.00%)
Aug 7, 2026, 4:10 PM AEST
Mesoblast Market Cap
Mesoblast has a market cap or net worth of 2.9 billion as of August 7, 2026. Its market cap has decreased by -6.75% in one year.
Market Cap
2.90B
Enterprise Value
2.91B
Revenue
98.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.23
ChartMarket Cap Chart
Since December 16, 2004, Mesoblast's market cap has increased from 76.57M to 2.90B, an increase of 3,686.20%. That is a compound annual growth rate of 18.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 2.90B | -16.92% |
| Dec 31, 2025 | 3.49B | -1.80% |
| Dec 31, 2024 | 3.55B | 1,029.56% |
| Dec 29, 2023 | 314.59M | -50.91% |
| Dec 30, 2022 | 640.82M | -29.87% |
| Dec 31, 2021 | 913.81M | -30.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Telix Pharmaceuticals | 5.11B |
| Neuren Pharmaceuticals | 2.73B |
| PYC Therapeutics | 2.09B |
| Clarity Pharmaceuticals | 999.86M |
| Clinuvel Pharmaceuticals | 470.49M |
| Tetratherix | 400.04M |
| Racura Oncology | 396.99M |
| Starpharma Holdings | 336.92M |